Arax Advisory Partners’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,063
| Closed | -$22.1K | – | 2906 |
|
|
2024
Q4 | $22.1K | Sell |
4,063
-1,509
| -27% | -$8.22K | ﹤0.01% | 1171 |
|
|
2024
Q3 | $46.3K | Buy |
5,572
+1,332
| +31% | +$11.1K | ﹤0.01% | 749 |
|
|
2024
Q2 | $30.4K | Buy |
+4,240
| New | +$30.4K | ﹤0.01% | 832 |
|
|
2023
Q1 | – | Sell |
-118
| Closed | -$1.69K | – | 1300 |
|
|
2022
Q4 | $1.69K | Hold |
118
| – | – | ﹤0.01% | 971 |
|
|
2022
Q3 | $3K | Hold |
118
| – | – | ﹤0.01% | 917 |
|
|
2022
Q2 | $3K | Hold |
118
| – | – | ﹤0.01% | 902 |
|
|
2022
Q1 | $4K | Hold |
118
| – | – | ﹤0.01% | 836 |
|
|
2021
Q4 | $5K | Hold |
118
| – | – | ﹤0.01% | 765 |
|
|
2021
Q3 | $6K | Sell |
118
-145
| -55% | -$7.37K | ﹤0.01% | 738 |
|
|
2021
Q2 | $11K | Buy |
+263
| New | +$11K | ﹤0.01% | 653 |
|